rxstatShortages › Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Toxoid Diphtheria Toxoid

Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Toxoid Diphtheria Toxoid shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Toxoid Diphtheria Toxoid products are in shortage in Canada (1 of 1 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 31, 2026.
Products affected
1 / 1
In shortage since
May 29, 2026
Est. full return
Aug 31, 2026
Reports on file
3
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
BOOSTRIX
2.5MCG 20UNIT 8MCG 8MCG 2UNIT · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02247600 · since May 29, 2026, est. end Aug 31, 2026 · Disruption of the manufacture of the drug.
Resolved
BOOSTRIX
2.5MCG 8MCG 8MCG 20UNIT 2UNIT · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02247600 · ended Apr 11, 2025 · Disruption of the manufacture of the drug.
Resolved
BOOSTRIX
2.5MCG 8MCG 8MCG 20UNIT 2UNIT · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02247600 · ended May 15, 2023 · Delay in shipping of the drug.

What's happening

Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Toxoid Diphtheria Toxoid is currently affected by an active shortage report filed with Health Canada by GLAXOSMITHKLINE INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Toxoid Diphtheria Toxoid is classified under “BACTERIAL VACCINES” (ATC J07AX).

Recent changes

Common questions

When will Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Toxoid Diphtheria Toxoid be back in stock in Canada?

The latest manufacturer estimate is Aug 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Toxoid Diphtheria Toxoid in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (bacterial vaccines)

No current shortageCorynebacterium Diphtheriae Crm-197 Protein Meningococcal Group C Oligosaccharide Meningococcal Group W-135 Oligosaccharide Meningococcal Group A Oligosaccharide Meningococcal Group Y OligosaccharideDiscontinuedCorynebacterium Diphtheriae Crm-197 Protein Pneumococcal Polysaccharide Serotype 1 Pneumococcal Polysaccharide Serotype 5 Pneumococcal Polysaccharide Serotype 4 Pneumococcal Polysaccharide Serotype 6b Pneumococcal Polysaccharide Serotype 9v Pneumococcal Polysaccharide Serotype 3 Pneumococcal Polysaccharide Serotype 19a Pneumococcal Polysaccharide Serotype 14 Pneumococcal Polysaccharide Serotype 19f Pneumococcal Polysaccharide Serotype 18c Pneumococcal Polysaccharide Serotype 23f Pneumococcal Polysaccharide Serotype 6a Pneumococcal Polysaccharide Serotype 7f0 of 1 reported products affectedNo current shortageCorynebacterium Diphtheriae Crm-197 Protein Pneumococcal Polysaccharide Serotype 3 Pneumococcal Polysaccharide Serotype 20a Pneumococcal Polysaccharide Serotype 9n Pneumococcal Polysaccharide Serotype 17f Pneumococcal Polysaccharide Serotype 22f Pneumococcal Polysaccharide Serotype 11a Pneumococcal Polysaccharide Serotype 15a Pneumococcal Polysaccharide Serotype 24f Pneumococcal Polysaccharide Serotype 35b Pneumococcal Polysaccharide Serotype 33f Pneumococcal Polysaccharide Serotype 23a Pneumococcal Polysaccharide Serotype 6a Pneumococcal Polysaccharide Serotype 16f Pneumococcal Polysaccharide Serotype 12f Pneumococcal Polysaccharide Serotype Deoac15b Pneumococcal Polysaccharide Serotype 8 Pneumococcal Polysaccharide Serotype 19a Pneumococcal Polysaccharide Serotype 10a Pneumococcal Polysaccharide Serotype 31 Pneumococcal Polysaccharide Serotype 7f Pneumococcal Polysaccharide Serotype 23bDiscontinuedHaemophilus Influenzae Type B-prp / Tetanus Toxoid Conjugate0 of 1 reported products affectedDiscontinuedMeningococcal Group C Oligosaccharide Corynebacterium Diphtheriae Crm-197 Protein0 of 2 reported products affectedDiscontinuedMeningococcal Polysaccharide Antigen Group A Meningococcal Polysaccharide Antigen Group C Meningococcal Polysaccharide Antigen Group W-135 Meningococcal Polysaccharide Antigen Group Y0 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.